Announced Tue, 18 Aug · 11:18 IST
Promoter Docon releases pledge on 1.75 crore Thyrocare shares
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-6.5%1-day move
₹620.00
prior close
₹609.10
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.1+0.3-6.5-8.5-8.7———————
Up moveDown movePending
AI summary
Promoter Docon Technologies has released the pledge on 1,75,00,000 Thyrocare shares (10.99% of equity capital) pledged with Catalyst Trusteeship as security for NCDs worth Rs 1,050 crore issued by API Holdings, Docon's parent company. Docon's total shareholding remains unchanged at 9,69,69,696 shares (60.92% of equity). After release, encumbered shares fell from 9,69,69,696 to 7,94,69,696, bringing the encumbrance ratio down from 60.92% to 49.93% of equity capital.
Likely market impact
Positive: pledge release cuts encumbered holding to 49.93%, easing overhang fears and promoter-level debt risk for shareholders.